Polymeric in situ forming depots have emerged as highly promising drug delivery systems
for long-acting applications. Their effectiveness is attributed to essential characteristics such …

In situ forming implants, defined as liquid formulations that generate solid or semisolid
depots following administration, have shown a range of advantages in drug delivery. This …

Introduction Poly (lactic-co-glycolic acid)(PLGA) has been used in many long-acting drug
formulations, which have been approved by the US Food and Drug Administration (FDA) …

Microencapsulation is an effective method to incorporate environmentally sensitive bioactive
compounds into small capsules to increase stability and bioavailability. The morphological …

This study was aimed towards the development of a novel microfluidic approach for the
preparation of (co) polymeric and hybrid nanoparticles (NPs) composed of (co) …

In situ forming implants are exposed to an extracellular matrix resembling a gel rather than
aqueous solution upon subcutaneous administration. The aim of study was to develop a gel …

Tuberculosis (TB) is a communicable disease caused by Mycobacterium tuberculosis (Mtb)
and is a major cause of morbidity and mortality. Successful treatment requires strict …

This study aimed to investigate different types of morphologies obtained using the
electrospinning process to produce a material that enables wound healing while performing …

In-situ forming implants (ISFIs) represent a simple, tunable, and biodegradable polymer-
based platform for long-acting drug delivery. However, drugs with different physicochemical …

Plantago major L. is a plant available worldwide that has been traditionally used for several
medical applications due to its wound healing, anti-inflammatory, and antimicrobial …